Details

---

• Active Ingredient: Medroxyprogesterone acetate 150 mg/mL.

• Registration Number (MAL): MAL19872273AZ

• Manufacturer: Pfizer Manufacturing Belgium NV 

 

Content

• Active Ingredient: Medroxyprogesterone acetate 150 mg/mL.

• Excipients: Includes methylparaben, propylparaben, sodium chloride, macrogol 3350, polysorbate 80, hydrochloric acid, sodium hydroxide, and water for injection.

• Appearance: White, sterile, aqueous suspension.

Indications

• Contraception: Long-term suppression of ovulation.

• Gynecology: Treatment of endometriosis and menopausal vasomotor symptoms.

• Oncology: Adjunctive and/or palliative treatment of recurrent and/or metastatic endometrial or renal carcinoma; treatment of hormonally-dependent, recurrent breast cancer in postmenopausal women.

Instructions

• Administration: Injectable suspension should be shaken well before use. Administer 150 mg intramuscularly every 3 months.

• Injection Sites: Gluteal or deltoid muscle; not for subcutaneous use.

• Contraindications: Avoid use during pregnancy and in patients with known or suspected hormone-dependent malignancies.